Effect of IL-13 on cytokines, cytokine receptors and inhibitors on human osteoarthritis synovium and synovial fibroblasts

Osteoarthritis and Cartilage

Volumn 6, Issue 1, 1998, Pages 40-49

  Jovanovic, Dragan ^a   Pelletier, Jean Pierre ^a   Alaaeddine, Nada ^a   Mineau, François ^a   Geng, Changshan ^a   Ranger, Pierre ^b   Martel Pelletier, Johanne ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

IL 13; Osteoarthritis; Proinflammatory cytokines; Synovial membrane

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 1BETA; METALLOPROTEINASE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING AFFINITY; ENZYME ACTIVITY; FIBROBLAST; INFLAMMATION; OSTEOARTHRITIS; PRIORITY JOURNAL; RECEPTOR BINDING; RNA ANALYSIS; SYNOVIUM;

EID: 0031923501     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1997.0091     Document Type: Article

References (32)

1. 1. Pelletier JP, Martel-Pelletier J, Howell DS. Etiopathogenesis of osteoarthritis. In: McCarthy DJ, Koopman WJ., Eds. Arthritis and Allied Conditions. A Textbook of Rheumatology, Philadelphia: Lea & Febiger 1996:1969-84.
2. 2. Pelletier JP, McCollum R, Cloutier JM, Martel-Pelletier J. Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. J Rheumatol 1995;22:109-14.
3. 3. Kammermann JR, Kincaid SA, Rumph PF, Baird DK, Visco DM. Tumor necrosis factor-α (TNF-α) in canine osteoarthritis: immunolocalization of TNF-α, stromelysin and TNF receptors in canine osteoarthritic cartilage. Osteoarthritis Cart 1996; 4:23-34.
4. 4. Vignon E, Balblanc JC, Mathieu P, Louisot P, Richard M. Metalloprotease activity, phospholipase A2 activity and cytokine concentration in osteoarthritis synovial fluids. Osteoarthritis Cart 1993;1:115-20.
5. 5. Farahat MN, Yanni G, Poston R, Panayi GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993;52:870-5.
6. 6. Pelletier JP, Martel-Pelletier J. Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: protective effect of NSAID. J Rheumatol 1989;16:19-27.
7. 7. Pelletier JP, Faure MP, DiBattista JA, Wilhelm S, Visco D, Martel-Pelletier J. Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study. Am J Pathol 1993; 142:95-105.
8. 8. Pelletier JP, Caron JP, Evans C, et al. In vivo suppression of early experimental osteoarthritis by IL-Ra using gene therapy. Arthritis Rheum 1997; 40:1012-19.
9. 9. Caron JP, Fernandes JC, Martel-Pelletier J, et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression. Arthritis Rheum 1996;39: 1534-44.
10. 10. Arend WP. Interleukin-1 receptor antagonist. A new member of the interleukin-1 family. J Clin Invest 1991;88:1445-51.
11. 11. Hart PH, Ahern MJ, Jones CA, Jones KL, Smith MD, Finlay-Jones JJ. Synovial fluid macrophages and blood monocytes differ in their responses to IL-4. J Immunol 1993;151:3370-80.
12. 12. Donnelly RP, Crofford LJ, Freeman SL, et al. Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-κB activity in monocytes and fibroblasts. J Immunol 1993;151:5603-12.
13. 13. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin Exp Immunol 1995;99:331-7.
14. 14. McKenzie ANJ, Culpepper JA, De Waal Malefyt R, et al. Interleukin-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993;90:3735-9.
15. 15. Defrance T, Carayon P, Billian G, et al. Interleukin 13 is a B cell stimulating factor. J Exp Med 1994; 179:135-43.
16. 16. de Waal Malefyt R, Figdor CE, Huijbens R, et al. Effects of IL-13 on the phenotype, cytokine production, and cytotoxic function of human monocytes. J Immunol 1993;151:6370-81.
17. 17. Herbert JM, Savi P, Laplace MC, et al. IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett 1993;328:268-70.
18. 18. Doherty TM, Kastelein R, Menon S, Coffman RL. Modulation of murine macrophage function by IL-13. J Immunol 1993;151:7151-60.
19. 19. Ulfgren A-K, Lindblad S, Klareskog K, Andersson J, Anderson U. Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1995;54: 654-67.
20. 20. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
21. 21. Sadouk M, Pelletier JP, Tardif G, Kiansa K, Cloutier JM, Martel-Pelletier J. Human synovial fibroblasts coexpress interleukin-1 receptor type I and type II mRNA: The increased level of the interleukin-1 receptor in osteoarthritic cells is related to an increased level of the type 1 receptor. Lab Invest 1995;73:347-55.
22. 22. Alaaeddine N, DiBattista JA, Pelletier JP, et al. Osteoarthritic synovial fibroblasts possess an increased level of TNF-R55 which mediates biological activation by TNF-α. J Rheumatol 1997; 24;1985-94.
23. 23. Ounissi-Benkalha H, Pelletier JP, Tardif G, et al. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of pro inflammatory cytokines in synovial membranes from patients with rheumatoid arthritis. J Rheumatol 1996;23: 16-23.
24. 24. Pelletier JP, Mineau F, Ranger P, Tardif G, Martel-Pelletier J. The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cart 1996;4:77-84.
25. 25. Pelletier JP, McCollum R, DiBattista JA, Loose LD, Cloutier J-M, Martel-Pelletier J. Regulation of human normal and osteoarthritic chondrocyte interleukin-1 receptor by antirheumatic drugs. Arthritis Rheum 1993;36:1517-27.
26. 26. Chavira R Jr, Burnett TJ, Hageman JH. Assaying proteinases with azocoll. Anal Biochem 1984;136: 446-50.
27. 27. Martel-Pelletier J, McCollum R, DiBattista JA, et al. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum 1992;35:530-40.
28. 75 by cytokines and growth factors in human synovial fibroblasts. J Rheumatol 1995;22:115-9.
29. 29. Corti A, Poiesi C, Merli S, Cassani G. Tumor necrosis factor (TNF) alpha quantification by ELISA and bioassay: effects of TNF alpha-soluble TNF receptor (p55) complex dissociation during assay incubations. J Immunol Methods 1994; 177: 191-8.
30. 30. Colotta F, Re F, Muzio M, et al. Interleukin-13 induces expression and release of interleukin decoy receptor in human polymorphonuclear cells. J Biol Chem 1994;269:12403-6.
31. 31. Tartaglia LA, Pennica D, Goeddel DV. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 1993;268(25):18542-8.
32. 32. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992;175:323-9.